Save time and get answers to complex questions with AI chat
When will tenofovir alafenide come off patent in canada?Dabrafenib and trametinib price?Diltiazem drug class?Mebendazole ingredients?When is the expected fda decision date for apotex's ruxolitinib resubmission?
See the DrugPatentWatch profile for rayaldee
Rayaldee (calcifediol) is used to treat vitamin D deficiency in people with chronic kidney disease (CKD), especially when they are not getting enough vitamin D through sunlight or diet. It helps raise and maintain adequate vitamin D levels in the body.
In CKD, the kidneys may not convert vitamin D into its active forms efficiently. Rayaldee is a form of vitamin D (calcifediol) that is more directly usable by the body to support vitamin D status.
Rayaldee is prescribed as part of managing CKD-related vitamin D deficiency, a common issue that can contribute to problems with mineral balance.
Rayaldee is specifically indicated for vitamin D deficiency in people with CKD (the usual intended use is not for the general population). For people without CKD, clinicians may use other vitamin D products depending on the cause of deficiency.
Other Questions About Rayaldee :